Absci’s Sean McClain and Gregory Hannum featured on Gradient Dissent podcast
Dec 03, 2021
Absci founder and CEO Sean McClain and Absci VP of AI Research Gregory Hannum recently appeared on Weights and Biases’ machine learning podcast Gradient Dissent to talk about the power of using AI for drug discovery. Among several topics covered, Sean and Greg discussed why Absci started investing heavily in machine learning research, what it’ll take to build the GPT-3 of DNA, and where the future of pharma is headed. Sean and Greg also reflected on some of the challenges of building cross-functional teams and combining two highly specialized fields like biology and machine learning.
Watch their full appearance here: